Controlling spending for prescription drugs

被引：21

作者：

Altman, SH ^{[1
]}

Parks-Thomas, C ^{[1
]}

机构：

[1] Brandeis Univ, Waltham, MA 02254 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2002年 / 346卷 / 11期

关键词：

D O I：

10.1056/NEJM200203143461113

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：855 / 856

页数：3

共 7 条

[1]

*CTR MED MED SERV, 2001, NAT HLTH EXP PROJ 20

[2] Compliance among pharmacies in California with a prescription-drug discount program for Medicare beneficiaries [J].

Lewis, JH ;

Schonlau, M ;

Muñoz, JA ;

Asch, SM ;

Rosen, MR ;

Yang, H ;

Escarce, JJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (11) :830-835

[3] Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors [J].

Schneeweiss, S ;

Walker, AM ;

Glynn, RJ ;

Maclure, M ;

Dormuth, C ;

Soumerai, SB .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (11) :822-829

[4]

STUART B, 2000, PRESCRIPTION DRUGS C

[5] Growth in prescription drug spending among insured elders [J].

Thomas, CP ;

Ritter, G ;

Wallack, SS .

HEALTH AFFAIRS, 2001, 20 (05) :265-277

[6]

WALLACK SS, 2001, RECENT TRENDS PRESCR

[7]

Zhan Chunliu, 2001, JAMA (Journal of the American Medical Association), V286, P2823

← 1 →